Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study - PubMed (original) (raw)
Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study
Marc R Larochelle et al. Ann Intern Med. 2016.
Abstract
Background: Nonfatal opioid overdose is an opportunity to identify and treat substance use disorders, but treatment patterns after the overdose are unknown.
Objective: To determine prescribed opioid dosage after an opioid overdose and its association with repeated overdose.
Design: Retrospective cohort study.
Setting: A large U.S. health insurer.
Participants: 2848 commercially insured patients aged 18 to 64 years who had a nonfatal opioid overdose during long-term opioid therapy for noncancer pain between May 2000 and December 2012.
Measurements: Nonfatal opioid overdose was identified using International Classification of Diseases, Ninth Revision, Clinical Modification, codes from emergency department or inpatient claims. The primary outcome was daily morphine-equivalent dosage (MED) of opioids dispensed from 60 days before to up to 730 days after the index overdose. We categorized dosages as large (≥100 mg MED), moderate (50 to <100 mg MED), low (<50 mg MED), or none (0 mg MED). Secondary outcomes included time to repeated overdose stratified by daily dosage as a time-varying covariate.
Results: Over a median follow-up of 299 days, opioids were dispensed to 91% of patients after an overdose. Seven percent of patients (n = 212) had a repeated opioid overdose. At 2 years, the cumulative incidence of repeated overdose was 17% (95% CI, 14% to 20%) for patients receiving high dosages of opioids after the index overdose, 15% (CI, 10% to 21%) for those receiving moderate dosages, 9% (CI, 6% to 14%) for those receiving low dosages, and 8% (CI, 6% to 11%) for those receiving no opioids.
Limitation: The cohort was limited to commercially insured adults.
Conclusion: Almost all patients continue to receive prescription opioids after an overdose. Opioid discontinuation after overdose is associated with lower risk for repeated overdose.
Primary funding source: Health Resources and Services Administration.
Comment in
- Most US patients continue to be prescribed opioids after overdose.
Wise J. Wise J. BMJ. 2016 Jan 3;352:h7010. doi: 10.1136/bmj.h7010. BMJ. 2016. PMID: 26729918 No abstract available. - Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose.
Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Larochelle MR, et al. Ann Intern Med. 2016 Sep 6;165(5):376-7. doi: 10.7326/L16-0168. Ann Intern Med. 2016. PMID: 27595218 No abstract available. - Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose.
Sullivan CT. Sullivan CT. Ann Intern Med. 2016 Sep 6;165(5):376. doi: 10.7326/L16-0169. Ann Intern Med. 2016. PMID: 27595219 No abstract available.
Similar articles
- Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
Nguyen AP, Glanz JM, Narwaney KJ, Binswanger IA. Nguyen AP, et al. JAMA Netw Open. 2020 Mar 2;3(3):e201018. doi: 10.1001/jamanetworkopen.2020.1018. JAMA Netw Open. 2020. PMID: 32219404 Free PMC article. - Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
Kennedy MC, Crabtree A, Nolan S, Mok WY, Cui Z, Chong M, Slaunwhite A, Ti L. Kennedy MC, et al. PLoS Med. 2022 Dec 1;19(12):e1004123. doi: 10.1371/journal.pmed.1004123. eCollection 2022 Dec. PLoS Med. 2022. PMID: 36454732 Free PMC article. - Follow-up to Nonfatal Opioid Overdoses: More of the Same or an Opportunity for Change?
Gregg J. Gregg J. Ann Intern Med. 2016 Jan 5;164(1):62-3. doi: 10.7326/M15-2687. Epub 2015 Dec 29. Ann Intern Med. 2016. PMID: 26720852 No abstract available. - Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pergolizzi J, et al. Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626 - Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy.
Park TW, Lin LA, Hosanagar A, Kogowski A, Paige K, Bohnert AS. Park TW, et al. J Addict Med. 2016 Nov/Dec;10(6):369-381. doi: 10.1097/ADM.0000000000000245. J Addict Med. 2016. PMID: 27525471 Review.
Cited by
- Murder Liability for Prescribing Opioids: A Way Forward?
Yang YT, Haffajee RL. Yang YT, et al. Mayo Clin Proc. 2016 Oct;91(10):1331-1335. doi: 10.1016/j.mayocp.2016.06.018. Epub 2016 Aug 5. Mayo Clin Proc. 2016. PMID: 27502463 Free PMC article. - Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist.
Thakarar K, Weinstein ZM, Walley AY. Thakarar K, et al. Postgrad Med J. 2016 Jun;92(1088):356-63. doi: 10.1136/postgradmedj-2015-133720. Epub 2016 Mar 22. Postgrad Med J. 2016. PMID: 27004476 Free PMC article. Review. - Association between prescribed opioid dose and risk of motor vehicle crashes.
Quinn PD, Chang Z, Pujol TA, Bair MJ, Gibbons RD, Kroenke K, D'Onofrio BM. Quinn PD, et al. Pain. 2023 Apr 1;164(4):e228-e236. doi: 10.1097/j.pain.0000000000002790. Epub 2022 Sep 26. Pain. 2023. PMID: 36155384 Free PMC article. - Assessing opioid overdose risk: a review of clinical prediction models utilizing patient-level data.
Tseregounis IE, Henry SG. Tseregounis IE, et al. Transl Res. 2021 Aug;234:74-87. doi: 10.1016/j.trsl.2021.03.012. Epub 2021 Mar 21. Transl Res. 2021. PMID: 33762186 Free PMC article. Review. - Validation of an administrative claims coding algorithm for serious opioid overdose: A medical chart review.
Mountcastle SB, Joyce AR, Sasinowski M, Costello N, Doshi S, Zedler BK. Mountcastle SB, et al. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1422-1428. doi: 10.1002/pds.4886. Epub 2019 Sep 4. Pharmacoepidemiol Drug Saf. 2019. PMID: 31483548 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical